Perseus 將其旗艦產品 PEGASUS 汽車虛擬化管理程式導入 Infineon AURIX™ TC4Dx 平台 Business

Perseus 將其旗艦產品 PEGASUS 汽車虛擬化管理程式導入 Infineon AURIX™ TC4Dx 平台

(SeaPRwire) - SEOUL, South Korea, March 11, 2026 — Perseus (www.cyberperseus.com) 已針對 Infineon Technologies 的 AURIX™ TC4Dx 系統單晶片 (SoC) 評估平台推出其旗艦汽車虛擬機管理程式 PEGASUS,為 OEM 與一級供應商提供一條以生產為導向的路徑,以開發和測試用於下一代軟體定義汽車 (SDV) 的虛擬化混合關鍵性系統。這款通過 ISO 26262 ASIL-D 認證的 Type‑1 (裸機) 虛擬機管理程式現已在 TC4Dx 評估硬體上提供,工具和文件可透過 Infineon 的生態系統管道取得。 此次發布標誌著 Perseus 將 PEGASUS 適配至 TC4Dx 評估板的整合與啟用計畫完成,提供了一套工程師可直接使用的評估堆疊,將 TC4Dx 硬體功能與系統層級虛擬化需求緊密結合。這項整合解決方案旨在支援 SDV、區域化及安全關鍵性的汽車架構,讓開發人員能在生產級技術上原型化並推進整合式、符合安全標準的電子/電氣 (E/E) 平台。 現已提供的內容 使用 Infineon AURIX™ TC4Dx 評估硬體的工程師現在可以存取一套完整的虛擬化堆疊,專為真實系統評估與整合設計: PEGASUS 汽車虛擬機管理程式 Perseus 的旗艦系統軟體產品 Type-1 (裸機) 虛擬機管理程式 針對 CPU 和 MCU 架構通過 ISO 26262 ASIL-D 認證 支援混合關鍵性工作負載的嚴格隔離與確定性排程 PEGASUS 軟體開發套件 (Workbench) 系統層級配置與建置環境 虛擬機 (VM) 布局與資源分配 (CPU、記憶體、裝置) 的定義 設計階段驗證與可重複的映像生成 文件與參考資料 平台描述、整合指南與合作夥伴資訊透過 Infineon 的 IFX 生態系統與合作夥伴資料庫發布 PEGASUS 在 Infineon AURIX™ TC4Dx 評估硬體上的可用性支援真實系統評估與整合工作,而非概念驗證實驗。 技術背景 隨著軟體定義汽車 (SDV) 架構日趨成熟,OEM 面臨壓力,不僅要在應用級 SoC 上整合功能,還要在即時與安全關鍵性 MCU 領域內整合。Infineon 的 AURIX™ TC4Dx 系列(針對確定性執行與 ASIL-D 安全設計)為此整合提供了硬體基礎。PEGASUS 解決了在此類平台上安全整合工作負載所需的系統軟體層,在作業系統層之下強制實施隔離、資源控制與可預測行為。 「PEGASUS 是 Perseus 的旗艦汽車虛擬機管理程式,設計用於在定義安全、確定性與隔離性的系統層運作,」Perseus 創辦人 Sang-bum Suh 博士表示。「透過在 Infineon 的 TC4Dx 評估硬體上啟用 PEGASUS 並公開工具與文件,我們為工程團隊提供了一種實用方式,來評估用於生產導向 SDV 架構的 MCU 層級虛擬化。」 「Infineon 的 AURIX™ TC4Dx 微控制器旨在支援需要強大安全與即時特性的先進汽車架構,」Infineon Technologies 軟體、合作夥伴與生態系統管理主管 Thomas Schneid 表示。「透過我們的生態系統提供 PEGASUS,為客戶提供了額外選項,可在 TC4Dx 上評估基於虛擬機管理程式的虛擬化,作為其系統架構與平台評估的一部分。」 關於 Perseus Perseus 是一家汽車系統軟體公司,專注於軟體定義汽車 (SDV) 的基礎系統軟體。Perseus 的產品組合包括 PEGASUS(一款針對 CPU 和 MCU 架構、通過 ISO 26262 ASIL-D 認證的 Type-1 汽車虛擬機管理程式),以及互補的工具和系統軟體,旨在實現混合關鍵性工作負載的安全、確定性整合。Perseus 與汽車 OEM、一級和二級供應商以及半導體合作夥伴合作,支援生產導向的 SDV 平台。 照片 – http://rssdatabase.tickerwit.com/images/502/109502_7.png本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
西班牙因伊朗戰爭永久撤回駐以色列大使 News

西班牙因伊朗戰爭永久撤回駐以色列大使

(SeaPRwire) - 西班牙週二永久撤回了駐以色列大使,以表達對美國與以色列針對伊朗發動襲擊的反對,這使得兩國之間本已緊張的外交裂痕進一步加劇。西班牙政府在官方公報中正式終止了該大使的職務,並表示其駐特拉維夫大使館將無限期由代辦領導。馬德里曾在去年九月召回其大使,此前以色列曾譴責西班牙禁止載有武器前往以色列的飛機和船隻使用西班牙港口或領空的決定。以色列外交部長 Gideon Sa’ar 當時稱此舉為反猶太主義。當週三有記者詢問西班牙總體上是否在與美國合作時,總統 Donald Trump 回答道:「沒有,他們沒有。我認為他們根本沒有在合作。」「我認為西班牙的表現非常糟糕,」總統說。「非常糟糕。一點也不好。我們可能會切斷與西班牙的貿易。」「我不知道西班牙在做什麼,」Trump 繼續說道。「他們對 NATO 的態度一直很糟糕。他們受到保護,卻不想支付公平的份額。多年來一直都是這樣。」Trump 補充說,西班牙人民「非常棒」,但領導層「不怎麼樣」。南卡羅來納州共和黨參議員 Lindsey Graham 週三批評西班牙永久召回駐以色列大使的決定,稱其「讓我難以接受」。「西班牙是 NATO 的成員國,而美國和以色列正在對伊朗政權進行聯合行動,該政權公開呼籲摧毀猶太國家,攻擊西方,並試圖以自己的形象淨化伊斯蘭教,」Graham 在 X 上寫道。「伊朗的宗教納粹政權才是問題所在,而不是猶太國家,」這位參議員繼續說道。「我希望西班牙的行動不會鼓勵伊朗那個虐待本國人民的暴虐、狂熱政權繼續堅持下去。」自從以色列為回應 2023 年 10 月 7 日 Hamas 的恐怖襲擊而在加薩發動軍事行動以來,西班牙與以色列之間的關係急劇惡化。去年五月,在西班牙承認巴勒斯坦國後,以色列也降低了其在西班牙的外交層級,將其駐馬德里大使館改由代辦領導。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
全球動盪中的明智投資 Business

全球動盪中的明智投資

(SeaPRwire) - 在地緣政治不確定時期,例如伊朗不斷變化的局勢,投資者常常發現自己處於十字路口。要麼逃離市場,要麼積極逢低買入的本能可能會非常強烈。然而,專家建議在這種動盪時期採取更為謹慎的投資方式。 一個關鍵策略是注重分散投資。通過將投資分散到一系列資產類別中,投資者可以降低風險。這種方法有助於緩衝任何單一市場的波動性,提供更穩定的投資軌跡。 此外,專家建議保持長期視角。地緣政治事件引發的短期波動往往是暫時的。通過保持穩定的方向並關注長期增長,投資者可以避免因反應性賣出或買入而陷入困境。 另一個關鍵因素是要了解資訊,但不要被新聞週期壓倒。雖然了解全球事件很重要,但僅僅根據煽情的頭條新聞做出投資決策可能會有害。相反,投資者應該依靠深入的研究和可靠的資訊來指導他們的投資策略。 對於那些希望投資特定行業的人來說,當前的地緣政治環境可能會在國防和能源類股票中帶來機會。這些行業的公司在衝突或不確定時期往往會看到需求增加。然而,在做出投資決策之前,評估每家公司的基本面和增長前景至關重要。 此外,投資者應該考慮制裁和經濟政策對國際市場的潛在影響。了解這些因素有助於預測市場走勢並相應地調整投資組合。 總之,雖然本能上可能會對地緣政治動盪做出強烈反應,但平衡且有根據的方法更有可能產生積極的結果。通過注重分散投資、保持長期視角並通過可靠的資訊來了解情況,投資者可以更有信心地應對波動的全球市場挑戰。 腳註: 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 地緣政治緊張局勢可能導致市場波動,但也會帶來投資機會。來源。 分散投資是在不確定時期降低風險的關鍵。來源。
More
2026年Oracle第三季盈利激增 Business

2026年Oracle第三季盈利激增

(SeaPRwire) - Oracle (NYSE:ORCL) 公布了2026年第三季度的亮眼收益,主要得益于其雲服務與授權支持收入的顯著增長。該公司向雲解決方案的戰略轉型持續帶來豐厚回報,使Oracle在競爭激烈的科技領域成為強大的參與者。第三季度期間,Oracle的總收入達到124億美元,較去年同期增長9%。這一增長主要由雲服務與授權支持收入19%的激增推動,該部分收入佔公司總收入的很大比例。Oracle的首席執行官強調了其雲基礎設施的強勁表現,這是公司財務成功的關鍵貢獻因素。該公司的雲業務(包括Oracle Cloud Infrastructure (OCI))已被多個行業採用,這些行業尋求增強的數據管理和分析能力。此外,Oracle專注於擴展其AI驅動的應用程序,吸引了新客戶,從而在各個領域(尤其是金融服務和醫療保健領域)的採用率有所提高。將AI和機器學習技術整合到其雲服務中,不僅提高了客戶的運營效率,還相對於Amazon Web Services和Microsoft Azure等競爭對手獲得了競爭優勢。Oracle的戰略收購也在提升其雲能力方面發揮了關鍵作用。通過收購與其現有服務互補的公司,Oracle能夠提供更全面的雲解決方案套件,從而強化其市場地位。該公司的營業收入為44億美元,同比增長10%,反映出其有效的成本管理和提供雲服務效率的提升。Oracle簡化運營的策略也促進了利潤率的改善,隨著雲業務不斷擴張,規模經濟帶來了益處。展望未來,Oracle仍對保持增長勢頭持樂觀態度。該公司專注於進一步增強其雲服務、投資數據中心,並擴大全球覆蓋範圍以開拓新市場。隨著對雲計算解決方案的需求不斷增加,Oracle處於有利地位,能夠利用這一趨勢並推動未來增長。儘管面臨競爭壓力和快速變化的科技格局,Oracle在雲領域的穩定表現凸顯了其戰略靈活性和對創新的承諾。投資者對該公司的長期前景仍抱有希望,因為Oracle繼續通過其尖端技術和以客戶為中心的方法提供價值。腳註: 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 Oracle的收入增長主要由雲服務的激增推動。來源。
More
猶太會堂在最新反猶太事件中遭槍擊,加拿大總理卡尼面臨採取行動的壓力 News

猶太會堂在最新反猶太事件中遭槍擊,加拿大總理卡尼面臨採取行動的壓力

(SeaPRwire) - 週末,多倫多的兩座猶太會堂遭到槍擊。幾天前,在猶太節日普林節期間,另一座會堂被約二十發子彈擊中。儘管這三次襲擊未造成人員受傷,但許多猶太社群人士要求總理馬克·卡尼採取具體行動——而不僅僅是此類反猶太主義事件後通常出現的安慰言辭。卡尼在 X 上表示,這些「反猶太和犯罪攻擊侵犯了加拿大猶太男女在完全安全中生活和祈禱的權利」,並「構成了對所有加拿大人生活方式的嚴重侵犯」。在第一次猶太會堂襲擊事件發生後,以色列國家安全委員會警告海外以色列人「保持警惕並遵守安全預防措施」。他們的建議包括以色列人應「在公共場所隱藏猶太和以色列的標識」,在「與以色列或猶太教有關的地區」注意周圍環境,並「避免前往被認定為猶太或以色列的場所」。在 X 上,以色列總統艾薩克·赫爾佐格表示「全世界都在關注加拿大:是時候阻止自 10 月 7 日以來爆發的史無前例的仇視猶太人浪潮了」。與許多西方國家一樣,自 2023 年 10 月 7 日哈馬斯在以色列發動恐怖襲擊以來,加拿大的年度反猶太主義事件顯著增加。加拿大 B'nai Brith 人權聯盟發現,2024 年加拿大發生了 6,219 起反猶太主義事件。這相當於平均每天 17 起,是 2022 年計算出的每天 8 起的兩倍多。儘管 2025 年的數據尚未公佈,但加拿大公共安全部指出,2025 年 4 月至 6 月期間,「在針對宗教的仇恨犯罪中……絕大部分針對猶太社群 (69%)」。保守黨議員羅曼·巴貝爾表示,加拿大總理馬克·卡尼和其他自由派加拿大政治人物的行為一直在「為加拿大的仇視猶太人火上澆油」。巴貝爾對卡尼進行了進一步的批評,他說:「當當總理在競選活動中說他知道加沙正在發生種族滅絕時,他就是在參與仇視猶太人。」巴貝爾指的是 2025 年 4 月發生的一件事,當時一名滋事者在喧囂的人群中大喊「加沙正在發生種族滅絕」。卡尼回應說:「我知道,這就是我們實施武器禁運的原因。」卡尼後來表示,他沒有聽到那名滋事者使用「種族滅絕」一詞。巴貝爾指出,「當總理承認巴勒斯坦國時,他獎勵了哈馬斯的殘暴行徑,而且他是在猶太新年前夕這樣做的。」在這份於猶太節日前一天發佈的聲明中,卡尼聲稱,承認「由巴勒斯坦權力機構領導的巴勒斯坦國,賦予了那些尋求和平共處和結束哈馬斯統治的人力量」,並「絕不會將恐怖主義合法化,也不是對其任何獎勵」。他還聲稱,承認巴勒斯坦國「絕不會損害加拿大對以色列國及其人民和安全的堅定支持」。監督組織 StopAntisemitism 告訴 Digital,「我們每天都看到痛苦的提醒,反猶太主義仍然是一個真實且危險的威脅。企圖恐嚇或讓我們社群閉嘴的暴力行為不會得逞。大聲且自豪的猶太人不會讓仇恨或恐懼阻礙我們的猶太生活方式或我們在世界上的存在。無論是在加拿大、美國、歐洲,當然還是在以色列。」StopAntisemitism 呼籲將肇事者「依法嚴懲,以伸張正義並起到明確的威懾作用」。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
美國在伊拉克的外交設施遭無人機攻擊 News

美國在伊拉克的外交設施遭無人機攻擊

(SeaPRwire) - 據《華盛頓郵報》(The Washington Post)報導,週二,親伊朗民兵發動的疑似報復性無人機攻擊擊中了美國在巴格達的一座主要外交設施。該報指出,攻擊擊中了巴格達外交支援中心(Baghdad Diplomatic Support Center),目前暫未傳出傷亡報告。共有六架無人機朝該設施發射,其中五架被擊落。《華盛頓郵報》援引一名安全官員和美國國務院的警示指出,一架無人機擊中了警衛塔附近,設施內人員被指示「蹲下掩護」(duck and cover)。「責任追究正在進行中,」該警示表示。伊拉克國防部在X平台上發文譴責針對烈士穆罕默德·阿拉空軍基地(Martyr Muhammad Alaa Air Base)和烈士阿里·法拉空軍基地(Martyr Ali Fallah Air Base)的無人機及飛彈攻擊,但未直接提及美國設施遇襲或伊朗。「針對這些罪惡的侵略行徑,國防部希望澄清並確認以下事實:這些空軍基地完全是伊拉克的主權領土,完全服從國家和法律的權威,任何名義下的外國部隊都未在其中駐紮,」政府賬號寫道。該安全官員告訴《華盛頓郵報》,攻擊可能是由與「伊拉克伊斯蘭抵抗組織」(Islamic Resistance in Iraq)有關聯的民兵發動的。該組織是一個由親伊朗的什葉派武裝派別組成的鬆散聯盟,曾宣稱對該地區針對美軍的攻擊負責。在「史詩之怒行動」(Operation Epic Fury)啟動之際,美國國務院敦促美國公民立即從中東十多個國家撤離,並警告隨著伊朗戰事升級,當地存在「嚴重安全風險」。負責領事事務的助理國務卿莫拉·納姆達爾(Mora Namdar)3月2日表示,美國公民應離開巴林、埃及、伊朗、伊拉克、以色列、約旦河西岸與加薩、約旦、科威特、黎巴嫩、阿曼、卡達、沙烏地阿拉伯、敘利亞、阿拉伯聯合大公國(United Arab Emirates)和葉門。國務院表示,需要協助透過商業管道撤離的美國人,可從國外撥打+1-202-501-4444,或從美國及加拿大撥打+1-888-407-4747,24小時聯繫國務院。官員警告,隨著與衝突相關的戰鬥持續,該地區局勢仍不穩定,安全狀況可能迅速變化。在伊朗對美軍和以色列發動報復性攻擊之初,至少九個美國使館(包括在巴林、伊朗、科威特、阿拉伯聯合大公國、沙烏地阿拉伯、伊拉克、約旦、卡達和以色列的使館)多次發布就地避難指令或警示。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Rheinmetall 2025年強勁的盈利增長 Business

Rheinmetall 2025年強勁的盈利增長

(SeaPRwire) - Rheinmetall 是國防與汽車產業的重要業者,已公佈2025會計年度的強勁獲利。該公司在法蘭克福證券交易所上市,代號為 RHM,其營收與利潤率均大幅成長,主要受兩大產業需求增加推動。 Rheinmetall 的國防部門因歐洲地緣政治緊張升級及隨之而來的軍事開支增加,業績大幅成長。國防產品(包括裝甲車輛和彈藥)需求的增加,使 Rheinmetall 得以獲取新合約,並擴大其全球市場份額。 在汽車領域,Rheinmetall 有效應對了供應鏈中斷及向電動車轉型的挑戰。透過專注於創新與永續發展,該公司推出了迎合汽車產業不斷演變需求的新技術,從而提升了競爭優勢。 Rheinmetall 的執行長對未來表示樂觀,指出研發方面的策略性投資預計將帶來穩健回報。該公司計劃進一步投資核心領域,同時探索新興市場的機會,尤其是亞洲和中東地區。 此外,Rheinmetall 宣布與數家科技公司建立策略合作關係,以強化其產品供應。此次合作旨在將尖端技術整合到 Rheinmetall 的國防與汽車產品中,確保其符合最高的效率與可靠性標準。 儘管前景樂觀,Rheinmetall 仍持謹慎樂觀態度,承認存在監管變動及原材料成本波動等潛在挑戰。不過,該公司仍對自身透過多元產品組合與全球布局來適應變化並維持成長的能力充滿信心。 整體而言,Rheinmetall 2025年的表現凸顯了其在應對複雜市場動態時的韌性與戰略遠見。該公司對創新、永續發展及策略合作的專注,使其在未來數年有望持續成功。 附註: 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 Rheinmetall 報告稱,由於地緣政治緊張升級,其國防部門業績大幅成長。來源。 該公司有效應對了汽車領域的供應鏈中斷問題。來源。
More
Yuexiu REIT Maintains Operational Resilience, Revenue Exceeds RMB1.8 Billion in 2025 ACN Newswire

Yuexiu REIT Maintains Operational Resilience, Revenue Exceeds RMB1.8 Billion in 2025

HONG KONG, Mar 11, 2026 - (ACN Newswire via SeaPRwire.com) – Yuexiu Real Estate Investment Trust ("Yuexiu REIT", together with Yuexiu REIT Asset Management Limited, collectively known as the “REIT”; stock code: 405) announced its annual results for the year ended 31 December 2025.Yuexiu REIT Management Team: Chairman and Non-Executive Director Mr. JIANG Guoxiong (center), Executive Director and Chief Executive Officer Ms. OU Haijing (left), and Chief Financial Officer Mr. KWAN Chi Fai (right)2025 Annual Results Highlights: - Overall operation remained resilient, with total revenue of RMB1,856 million (2024: RMB2,032 million).- The average financing cost was 3.61%, a three-year low; the average interest payment rate was 3.77%, representing a year-on-year decrease of 76 basis points. Excluding exchange loss, the financing expenses decreased by approximately RMB152 million year-on-year.- As at 31 December 2025, the overall occupancy rate of the properties was 82.1% (2024: 84.5%).- Optimised the asset portfolio by disposing of a 50% interest in Yuexiu Financial Tower in Q4 2025, realising cash proceeds of approximately RMB5.3 billion to enhance financial flexibility. Yuexiu REIT maintained its "investment-grade" rating from both Standard & Poor's and Fitch, with the outlook upgraded to "stable".- The final distribution to the Unitholders for the period will be approximately RMB0.0189, equivalent to HK$0.0214. Distribution per Unit for the year will be approximately RMB0.0522, equivalent to HK$0.0580. Distribution yield is 6.74% per Unit for the year.- To maintain the REIT’s financial flexibility, the distribution ratio for the period from 1 July 2025 to 31 December 2025 has been adjusted to 90%, resulting in an overall full-year distribution ratio of approximately 96%.Guangzhou International Finance Center (GZIFC):- Operating revenue of the GZIFC complex was RMB984 million, accounting for 53.0% of the REIT’s total revenue.- The office building of GZIFC introduced two Fortune Global 500 companies; the occupancy rate was 80.9%.- GZIFC Shopping Mall introduced China Duty Free Group (CDFG), the first and currently the only downtown duty-free store in Guangzhou, achieving a renewal rate of 89% for the year, and an occupancy rate of 95.5% at the end of the period.- Four Seasons Hotel Guangzhou's average room rate increased by 5.8% year-on-year. Ascott Serviced Apartments GZIFC achieved an average occupancy rate of 91.5%, up 1 percentage point year-on-year, with revenue reaching a record high for the period.Proactive Management of Financing Risk and Effective Stabilisation of Financing Cost- With regard to the short-term loan of RMB530 million, the 5-year syndicated loan of HK$2.1 billion, and the remaining HK$2.1 billion of the 3-year syndicated loan of HK$3.8 billion, all due in 2025, the Manager in 2025 renewed the short-term loan of RMB530 million, obtained offshore loan of RMB1.7 billion, issued dim sum bonds of RMB1 billion, and obtained an offshore syndicated loan package equivalent to HK$2.1 billion (a sustainability-linked loan), for the refinancing of the maturing loans so as to ensure effective monitor on the liquidity risk.- A total of approximately RMB4.68 billion in loans were obtained in 2025 to partially refinance offshore HKD floating rate loans, taking advantage of the relatively low-cost of RMB financing to proactively adjust the financing structure. At the end of 2025, the financing interest rate exposure of Yuexiu REIT was approximately 10%, narrowed by 16 percentage points from 26% at the beginning of the year; the average financing cost was 3.61%, a three-year low, representing a decrease of 55 basis points from 4.16% at the beginning of the year; the average interest payment rate for the full year of 2025 was 3.77%, representing a year-on-year decrease of 76 basis points. Excluding the exchange loss, the finance expenses were approximately RMB773 million, representing a year-on-year decrease of approximately RMB152 million.- As at the end of 2025, Yuexiu REIT had RMB financing of approximately RMB15.47 billion, accounting for 76% of total financing (2024: RMB financing of approximately RMB12.33 billion, accounting for 60% of total financing).Mr. JIANG Guoxiong, Chairman and Non-Executive Director of Yuexiu REIT, said, "2025 marked the 20th anniversary of Yuexiu REIT's listing. The Manager consolidated its competitive advantages by taking strategic actions to secure market share, prioritised occupancy rates, strengthened risk control to stabilise lease renewals, enhanced product competitiveness to meet market demand and invested in capital renovation projects to ensure asset value preservation and appreciation. These efforts stabilised the fundamentals of operations in a challenging market, providing solid support for the full-year revenue. Concurrently, we optimised the asset portfolio by appropriately reducing the proportion of office buildings, and proactively captured favourable financing opportunities, successfully issuing the first-ever Panda Bonds by a listed REIT globally as well as the REIT’s inaugural green bond. Financing costs for the year reached a three-year low, effectively underpinning the overall distribution level. The successful execution of a series of pioneering capital operations fully demonstrated the Manager’s strategic commitment to driving the high-quality development of Yuexiu REIT. This underscored its resolute determination in creating sustainable and long-term value for Unitholders.”Guangzhou International Finance Center (GZIFC)During the year, GZIFC recorded a newly contracted area of 15,702 sq.m. The newly launched 7,403 sq.m. of furnished units recorded an absorption cycle of about 36 days, with an absorption rate close to 72%. Quality tenants introduced include two Fortune Global 500 companies, a Fortune China 500 company, a leading global shipping giant, and a renowned Internet-based culture, sports and entertainment company. In addition, the project recorded a renewal area of 34,294 sq.m. and a renewal rate of 86%, retaining quality tenants including six Fortune Global 500 companies and a foreign consulate. GZIFC was selected as one of the Top 30 companies in the “Performance Index - 2025 Commercial Property Operation Performance)” by Guandian.GZIFC Shopping Mall renewed lease with its anchor tenant, Guangzhou Friendship Store, and introduced China Duty Free Group (CDFG) to set up a store, which is the first and currently the only downtown duty-free store in Guangzhou. In addition, GZIFC Shopping Mall launched the light meal and beverage area on the basement floor, coupled with the brand revitalisation of the dining tenants on the fourth and fifth floors by introducing seven “first stores”. Membership operations achieved remarkable results, with the share of member sales doubling to 16%. The project actively created digitalised consumption scenarios and made full use of mainstream platforms to attract customer flow through multiple channels. Specifically, the “Italian Culture Season” themed event was successfully held in collaboration with hotels, theaters, museums and consulates, effectively boosting customer flow and sales. Newly contracted area and renewal area totaled 35,573 sq.m., with a renewal rate of 89%. The occupancy rate was 95.5%.Four Seasons Hotel Guangzhou launched the first batch of renovated rooms during the year. The average room rate was RMB2,260, representing a year-on-year increase of 5.8%. The average occupancy rate was 77.7%. The revenue per available room (RevPAR) was RMB1,756, representing a year-on-year increase of 0.9%. The RevPAR competitive index was 110.0, maintaining a relatively leading market position among luxury hotel competitors. Ascott Serviced Apartments GZIFC recorded an average occupancy rate of 91.5% during the year, representing a year-on-year increase of 1 percentage point. The average room rate was RMB1,137, representing a year-on-year increase of 1.6%. The RevPAR was RMB1,040, representing a year-on-year growth of 2.7%. The RevPAR competitive index reached 146.9, remaining at a high level among high-end apartment competitors. The Apartments achieved a record high in operating revenue for the same period and ranked first in operating revenue among Ascott China properties for ten consecutive years since 2016.Yuexiu Financial TowerThe Manager disposed of 50% interest in Yuexiu Financial Tower in Q4 2025. Following completion of the disposal, Yuexiu Financial Tower became a Qualified Minority-owned Property of the REIT. The occupancy rate was 77.9% at the end of the period.White Horse BuildingWhite Horse Building introduced high-quality customers from core industrial clusters in Guangzhou, Shenzhen and Dongguan and recorded a newly contracted area of 5,808 sq.m. for the year, with full occupancy on the 1st floor for the first time in the past five years and a six-year record high set by the 2nd floor’s occupancy rate. During the year, it organised 22 original brands to showcase their products at professional exhibitions such as the Fashion World Tokyo, and the China International Fashion Fair; held the “White Horse Fashion Journey: Border Trade Supply Chain Matching Conference”, and established the “Guangdong-Xinjiang Fashion Industry Chain Supply and Procurement Cooperation Alliance” with ten wholesale markets in Urumqi, Xinjiang. During the year, it welcomed a total of 517 procurement delegations, along with nearly 13,000 purchaser visits, including 19 foreign delegations from France, Vietnam and other countries, and facilitated procurement deals worth RMB320 million. The occupancy rate was 96.0% at the end of the period.Fortune PlazaDuring the year, the project recorded a newly contracted area of 6,334 sq.m., and introduced certain quality tenants including several subsidiaries of a Fortune Global 500 integrated financial group, two Fortune Global 500 companies and the Guangzhou branch of two global leading companies. The project recorded a renewal area of 8,662 sq.m. and a renewal rate of 84.0%, retained quality tenants including three Fortune Global 500 companies and the Guangzhou branch of a national commercial bank. Upgraded product standards accelerated the absorption of vacant units, with an absorption rate of 93% for furnished units. The occupancy rate was 93.4% at the end of the period, representing a year-on-year increase of 1 percentage point, and a strong rebound of 5.4 percentage points from the interim period.City Development PlazaDuring the Reporting Year, the project recorded a newly contracted area of 9,279 sq.m. and introduced a beauty technology company and a pharmaceutical supply chain service company to enhance the ambience of healthcare business in the building. The project recorded a renewal area of 5,011 sq.m. and a renewal rate of 77%, retained tenants including a Fortune Global 500 company and a globally-renowned Contract Research Organisation (CRO). The occupancy rate was 90.6% at the end of the period.Victory PlazaVictory Plazq’s anchor tenant, Uniqlo, continued to play a flagship role, recording a 7.0% year-on-year sales growth for the year and maintaining its position as the top-selling store nationwide. The project successfully introduced the sports brand “Super Anta” to set up the largest store in the Guangzhou-Foshan region and “Crab Mang Mang”, the first store nationwide of Guizhou spicy crab business, achieved the diversification of its food and beverage brand portfolio. By connecting internal and external resources to hold fifteen major events, the mall achieved a year-on-year increase of 2.0% in its annual sales. During the year, newly contracted area and renewal area totaled 5,579 sq.m., with a renewal rate of 84%. The occupancy rate was 94.0% at the end of the period.Shanghai Yue Xiu TowerDuring the year, Shanghai Yue Xiu Tower recorded a renewal area of 6,430 sq.m., with a renewal rate of 43%, while securing a newly contracted area of 8,070 sq.m., efficiently making up for the prematurely vacated units. During the year, the project continued to increase the supply of small-area furnished units to meet market demand, formulated differentiated pricing strategies, and successfully held a channel recruitment conference, which attracted more than one hundred real estate agencies. By investing in various capital nature renovations, the project enhanced both energy efficiency and service standards. The occupancy rate was 83.1% at the end of the period.Wuhan PropertiesDuring the year, Wuhan Yuexiu Fortune Centre recorded a newly contracted area of 26,837 sq.m., and introduced quality tenants including two Fortune Global 500 state-owned enterprises, and two Fortune Global 500 foreign enterprises. In addition, it recorded a renewal area of 20,617 sq.m. and a renewal rate of 76.0%, hitting a new high in the past three years, and retained quality tenants, including seven Fortune Global 500 enterprises and a Fortune China 500 company. Approximately 21,000 sq. m. of renovated units were supplied throughout the year, with an absorption rate approaching 98%. The occupancy rate was 62.1% at the end of the period, representing a year-on-year increase of 1 percentage point.Wuhan Starry Victoria Shopping Centre revitalised several popular dining and fitness brands, aiming to attract more family and young customer groups. The project deeply tapped into the consumption potentials of “night economy” and “scene experience” by leveraging the unique venue feature of “Joy Garden”, launching themed activities such as “Riverside Starry Night ”, thus achieving customer flow substantially in line with last year, while the shopping mall recorded a year-on-year increase of 0.5% in annual sales. During the year, newly contracted area and renewal area totaled 9,827 sq.m., with a renewal rate of 48.0%. The occupancy rate was 87.4% at the end of the period, representing a rebound of 5.0 percentage points from the interim period.Hangzhou VictoryDuring the year, the project recorded a newly contracted area of 7,890 sq.m. and introduced a tenant to take up an entire floor. In addition, it recorded a renewal area of 8,836 sq.m. and a renewal rate of 54%, retained quality tenants including two Fortune Global 500 companies and the Zhejiang branch of a state-owned enterprise in Shanxi Province. The occupancy rate was 84.5% at the end of the period.Integrating ESG into Business and Promoting Sustainable DevelopmentAdhering to a long-term perspective, the Manager systematically advanced ESG initiatives. On the occasion of publicly disclosing Yuexiu REIT’s sustainability practices for the tenth consecutive year, the Manager officially renamed the “Environmental, Social and Governance Report” to the “Sustainability Report”, further promoting the deep integration of Yuexiu REIT’s strategy into sustainable development and reinforcing their synchronized progress. During the year, Yuexiu REIT received the highest Green Five Star rating and the title of “Global Sector Leader” for the first time from the Global Real Estate Sustainability Benchmark (GRESB) and once again secured A-rating (highest level) for public disclosure, highlighting its outstanding capabilities in the field of sustainable development.ProspectsIn the coming year, the Manager will maintain a prudent and optimistic attitude, adapt proactively to changes and strengthen risk managemen to generate stable return for the Unitholders. In terms of asset management, the Manager will dynamically implement proactive, prudent and flexible leasing and operating strategies in response to economic development trends and competitive dynamics, diligently explore new growth drivers, and keenly seize potential opportunities to enhance the market competitiveness of asset portfolio. In terms of financing management, the Manager will continue to review and make reasonable adjustments to its financing structure, and introduce low-cost RMB financing through various financing channels to offset interest rate risks. In respect of renovation projects, the Manager will carry out the phased renovations of Four Seasons Hotel Guangzhou in an orderly manner to support the long-term preservation and appreciation of property value.About Yuexiu Real Estate Investment TrustYuexiu Real Estate Investment Trust ("Yuexiu REIT") was listed on the Hong Kong Stock Exchange of Hong Kong Limited on 21 December 2005 and is the first listed real estate investment trust only investing in properties in the People's Republic of China (the "PRC") in the world. As of 31 December 2025, Yuexiu REIT’s portfolio of properties consisted of ten properties (including one Qualified Minority-owned Property), namely, White Horse Building, Fortune Plaza, City Development Plaza, Victory Plaza, Guangzhou International Finance Centre (“GZIFC”), Yuexiu Financial Tower (a Qualified Minority-owned Property with a 49.495% beneficial interest) located in Guangzhou; Yue Xiu Tower located in Shanghai; Wuhan Yuexiu Fortune Centre, and Starry Victoria Shopping Centre located in Wuhan; Victory Business Centre located in Hangzhou; and Yue Xiu Building located in Hong Kong. The total gross floor area of the properties (excluding Yuexiu Financial Tower) was approximately 974,000 sq.m. All properties are located in the central business district of Guangzhou, Shanghai, Wuhan, Hangzhou and Hong Kong respectively. The categories of the properties include Grade-A offices, commercial complexes, retail business, hotel, serviced apartments and professional clothing market etc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
雲頂新耀維適平(R)中國大陸首張處方落地 填補中重度潰瘍性結腸炎治療空白 ACN Newswire

雲頂新耀維適平(R)中國大陸首張處方落地 填補中重度潰瘍性結腸炎治療空白

香港, 2026年3月11日 - (亞太商訊 via SeaPRwire.com) - 雲頂新耀(01952.HK)宣佈,旗下自身免疫性疾病領域核心產品維適平(R)(精氨酸艾曲莫德片,VELSIPITY(R))中國大陸首張處方在3月9日於中山大學附屬第一醫院開出,標志著這款創新療法正式進入中國臨床應用階段。據悉,在中國大陸首方開具當天,維適平(R)已在廣州、上海、杭州、西安、重慶、北京和南京7個核心城市的8家三甲醫院同步開出處方,實現上市首日即覆蓋全國重點區域患者,並通過互聯網醫院渠道進一步擴大患者覆蓋範圍。目前,該藥物已在中山大學附屬第一醫院、浙江大學醫學院附屬邵逸夫醫院、中國人民解放軍空軍軍醫大學第一附屬醫院、重慶市人民醫院、中國醫學科學院北京協和醫院等多家核心醫療機構惠及患者。值得關注的是,維適平(R)於今年2月獲得國家藥監局批准上市,僅一個月便實現中國大陸首方落地,推進速度明顯快於行業平均水平。業內認為,這不僅反映出該產品較高的臨床需求,也體現了雲頂新耀在創新藥商業化方面的執行效率。從疾病負擔來看,炎症性腸病(IBD)已被認為是全球增長最快的消化系統疾病之一。IBD主要包括潰瘍性結腸炎(UC)和克羅恩病(CD)。近年來,隨著飲食結構變化、生活方式改變以及診斷水平提升,中國患者數量持續增加。多家行業研究機構預計,到2030年前後,中國IBD治療市場規模有望突破百億元人民幣,其中新型小分子創新藥將成為主要增長動力之一。從臨床需求來看,潰瘍性結腸炎是一種病因尚不明確、易複發的慢性腸道炎症性疾病,臨床表現為黏液血便、腹痛、腹瀉、裏急後重等症狀,嚴重影響患者長期生活質量。近年來,中國該病發病率和患病率持續上升且呈年輕化趨勢,預計患者人數將由2025年的約98萬增長至2031年的約150萬。目前該病仍無法治愈,患者需長期用藥維持疾病控制,而傳統療法療效有限、生物制劑存在「療效天花板」,臨床亟需能實現更穩定、持久疾病控制的創新方案。維適平(R)作為每日口服一次的新一代高選擇性S1P受體調節劑,具備最佳藥物(best-in-disease)潛質,已獲得美國胃腸病學協會(AGA)臨床實踐指南與美國胃腸病學會(ACG)臨床指南強烈推薦,作為中重度潰瘍性結腸炎的一線用藥。多項全球臨床研究證實其療效與安全性良好,尤其在快速起效、實現無激素緩解及深度黏膜愈合方面具有明顯臨床優勢。在迄今最大規模的中重度UC患者亞洲多中心III期臨床研究(ENLIGHT UC)中,維適平(R)維持治療40周,臨床緩解率達48.1%,深度黏膜愈合率達51.9%,內鏡正常化率達45.5%。數據顯示,維適平(R)可實現強效深度黏膜愈合,從而改善疾病長期預後,並有助於降低複發及癌變風險。全球Ⅲ期ELEVATE研究的一項開放標簽擴展研究數據證實,持續維適平(R)治療3年,在觀察病例中,86.8%患者實現臨床應答,臨床緩解率和黏膜愈合率均維持在約60%水平。全球臨床研究隨訪5年的數據進一步表明其穩定且良好的安全性特征,整體耐受性良好。中華醫學會消化病學分會前任主任委員、中山大學附屬第一醫院消化內科學術帶頭人陳旻湖教授指出,維適平(R)此次首張處方的開具,有望進一步優化潰瘍性結腸炎的臨床管理路徑,推動疾病治療向更高水平發展,實現黏膜愈合的治療目標,惠及更多患者。雲頂新耀首席執行官羅永慶表示,黏膜愈合是當前潰瘍性結腸炎的治療目標,盡早實現可大幅降低患者疾病複發率、住院率、手術率和癌變風險。維適平(R)可從源頭控制腸道炎症,促進黏膜愈合,填補了中重度潰瘍性結腸炎治療領域的空白。作為一款治療潰瘍性結腸炎的創新一線治療藥物,維適平(R)兼具「療效、安全性及方便性」三重優勢,為患者提供長期疾病控制與生活質量改善的保障。此外,該藥物於2024年和2025年被納入粵港澳大灣區內地9市臨床急需進口港澳藥品醫療器械目錄,在大灣區率先實現臨床應用,且在真實診療場景中的表現與臨床研究療效、安全性一致。商業化層面,雲頂新耀已通過腎科核心產品耐賦康(R)驗證了成熟可複制的商業化能力。作為全球首個且目前唯一在中、美、歐獲得完全批准的IgA腎病對因治療藥物,耐賦康(R)在2025年前三季度銷售額突破10億元,創造了非腫瘤產品的曆史,成為過去十年慢病藥進醫保銷售最好的產品。該產品的成功,驗證了以「科學及商業洞察驅動的准入、醫學、市場、銷售一體化協同(A2MS)」為核心的創新藥商業化運營平台,也為後續產品的市場拓展提供了可複用的體系與經驗。此次維適平(R)首方快速落地,進一步印證了該平台的高效性,依托耐賦康(R)的渠道網絡與市場准入經驗,其有望複刻增長路徑。從市場格局來看,長期以來中國潰瘍性結腸炎治療市場以傳統免疫抑制劑和注射型生物制劑為主,這些方案存在口服便利性不足、長期安全性風險等問題。維適平(R)憑借差異化優勢,被業界認為有望填補這一需求缺口,行業普遍預期其銷售峰值可達50億元,成為驅動雲頂新耀業績增長的重要引擎。雲頂新耀表示,將構建多渠道准入體系,提供多元化患者援助項目和創新支付方案,並全力推動維適平(R)納入國家醫保目錄,以提升藥物的可及性和可負擔性。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY(R) in Mainland China, Addressing Unmet Need in Moderately to Severely Active Ulcerative Colitis JCN Newswire

Everest Medicines Announces Commercial Launch and First Prescription for VELSIPITY(R) in Mainland China, Addressing Unmet Need in Moderately to Severely Active Ulcerative Colitis

HONG KONG, March 11, 2026 - (ACN Newswire via SeaPRwire.com) – March 9, Everest Medicines (1952.HK) announced the commercial launch of VELSIPITY(R) (etrasimod arginine tablets) in Mainland China, highlighted by the issuance of the first prescription at The First Affiliated Hospital of Sun Yat-sen University, marking a milestone in patient access in the region. According to reports, on the day the first prescription was issued in mainland China, VELSIPITY(R) was simultaneously prescribed in eight tertiary hospitals across seven key cities—Guangzhou, Shanghai, Hangzhou, Xi’an, Chongqing, Beijing, and Nanjing—achieving immediate coverage of patients in major regions nationwide on its launch day. The drug has also expanded patient access through internet hospital platforms. To date, patients at leading medical institutions, including the First Affiliated Hospital of Sun Yat-sen University, Sir Run Run Shaw Hospital, the First Affiliated Hospital of the Air Force Medical University of the People's Liberation Army, Chongqing People’s Hospital, and Peking Union Medical College Hospital, have already benefited from the therapy.Notably, VELSIPITY(R) was approved for marketing by China’s National Medical Products Administration (NMPA) in February this year. The first prescription in mainland China was issued just one month later, marking a rollout significantly faster than the industry average. Industry observers believe this not only reflects the strong clinical demand for the product but also demonstrates Everest Medicines’ execution capabilities in the commercialization of innovative drugs.From a disease burden perspective, inflammatory bowel disease (IBD) is considered one of the fastest-growing gastrointestinal diseases worldwide. IBD mainly includes ulcerative colitis (UC) and Crohn’s disease (CD). In recent years, the number of patients in China has continued to increase, driven by changes in dietary patterns, shifts in lifestyle, and improvements in diagnostic capabilities. Several industry research institutions predict that China’s IBD treatment market could exceed RMB 10 billion by around 2030, with novel small-molecule innovative drugs expected to become one of the key drivers of market growth.From a clinical perspective, ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease characterized by symptoms such as mucus and blood in the stool, abdominal pain, diarrhea, and rectal tenesmus, which can significantly affect patients’ quality of life. In China, both the incidence and prevalence of UC are increasing, with a clear trend toward younger patients. The patient population is projected to grow from approximately 0.98 million in 2025 to about 1.50 million by 2031. As the disease remains incurable, patients require long-term management to maintain disease control.VELSIPITY(R) is a next-generation, highly selective S1P receptor modulator with best-in-disease potential and strong first-line treatment recommendations for moderately to severely active ulcerative colitis (UC) in both the American Gastroenterological Association (AGA) Clinical Practice Guideline and the American College of Gastroenterology (ACG) Clinical Guideline Update.Results from multiple global clinical studies have demonstrated that VELSIPITY(R) delivers meaningful clinical benefits, including rapid onset of action, long-lasting clinical remission, steroid-free remission, and deep mucosal healing, with a favorable safety profile. In the ENLIGHT UC study, the largest Asian multicenter Phase 3 clinical study, the clinical remission rate at week 40 of the maintenance period reached 48.1%, and the deep mucosal healing rate reached 51.9%, with an endoscopic mucosal normalization rate of 45.5%. These findings demonstrate VELSIPITY(R)'s potential to improve long-term disease outcomes and reduce the risk of relapse and disease progression.Results from the ELEVATE UC open-label extension demonstrate continuous treatment with VELSIPITY(R) for up to 3 years resulted in 86.8% of patients achieving a clinical response among the observed cases, with both clinical remission and mucosal healing rates maintained at approximately 60%. Safety data extending up to five years from the global clinical program further confirm that VELSIPITY(R) is well tolerated and maintains a favorable and stable safety profile.Prof. Chen Minhu, Academic Leader of the Department of Gastroenterology at The First Affiliated Hospital of Sun Yat-sen University, noted that with the first prescription now issued, VELSIPITY(R) is being incorporated into routine clinical practice, providing physicians with an innovative treatment option for patients living with UC who continue to face ongoing disease challenges.“Early achievement of mucosal healing is recognized as a key treatment goal, as it can significantly reduce rates of disease relapse, hospitalization, surgery, and the risk of progression to colorectal cancer. VELSIPITY(R) addresses this need by targeting intestinal inflammation at its source and promoting mucosal healing, while offering a favorable profile of efficacy and safety, along with the convenience of an oral, once-daily regimen, supporting sustained disease management and improving patients' quality of life,” said Mr. Rogers Yongqing Luo, Chief Executive Officer of Everest Medicines.In 2024 and 2025, VELSIPITY(R) was included in the Catalogues of Guangdong Province on Drugs and Medical Devices from Hong Kong and Macao in Urgent Clinical Use in Nine Mainland Municipalities of the Guangdong-Hong Kong-Macao Greater Bay Area, making it available at designated hospitals across the region. Real-world data have shown that the efficacy and safety of VELSIPITY(R) are consistent with those observed in clinical trials.From a commercialization perspective, Everest Medicines has already demonstrated a mature and replicable capabilities through its core nephrology product NEFECON(R). As the world’s first and currently the only etiological treatment for IgA nephropathy (IgAN) to receive full approvals in China, the United States, and Europe, Nefecon(R) generated more than RMB 1 billion in sales in the first three quarters of 2025. The product has set a new benchmark for non-oncology therapies and has become one of the best-performing chronic disease drugs added to China’s national reimbursement list over the past decade.This achievement has validated the company’s platform for the commercialization of innovative medicines, centered on the integrated coordination of access, medical, marketing, and sales (A2MS) driven by scientific and commercial insights. It has also provided replicable systems and experience for the market expansion of future products. The rapid issuance of the first prescription for VELSIPITY(R) further demonstrates the efficiency of this platform. Leveraging the channel network and market access experience built through Nefecon(R), the product is expected to replicate a similar growth trajectory.From a market landscape perspective, China’s UC treatment market has long been dominated by traditional immunosuppressants and injectable biologics. However, these therapies present certain limitations, including lack of oral convenience and potential long-term safety risks. With its differentiated advantages, VELSIPITY(R) is widely viewed by the industry as having the potential to address this unmet need. Market expectations suggest that the drug could reach peak sales of RMB 5 billion, becoming a key driver of revenue growth for Everest Medicines.Everest Medicines stated that it plans to build a multi-channel market access framework, provide diversified patient assistance programs and innovative payment solutions, and actively pursue the inclusion of VELSIPITY(R) in China’s National Reimbursement Drug List (NRDL) to improve the drug’s accessibility and affordability. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
越秀房產基金經營保持韌性 2025年收入逾人民幣18億元 ACN Newswire

越秀房產基金經營保持韌性 2025年收入逾人民幣18億元

香港, 2026年3月11日 - (亞太商訊 via SeaPRwire.com) - 越秀房地產投資信託基金(「越秀房產基金」,連同越秀房託資產管理有限公司,統稱「基金」;股份代號:405)公佈其截至2025年12月31日止之全年業績。越秀房產基金管理團隊:主席及非執行董事江国雄先生(中)、執行董事及行政總裁區海晶女士(左)、財務總監關志輝先生(右)2025年全年業績摘要:- 整體經營保持韌性,收入總額為人民幣18.56億元(2024年:人民幣20.32億元)。- 平均融資成本為3.61%,創近三年新低;平均付息率3.77%,同比下降76個基點,剔除匯兌虧損的融資成本同比減少約1.52億元人民幣。- 於2025年12月31日,物業整體出租率為82.1%(2024年同期:84.5%)。- 優化資產組合,於第四季度出售越秀金融大廈50%權益,回籠約人民幣53億元現金提升財務靈活度,獲標普和惠譽維持「投資級」評級,並上調評級展望至「穩定」。- 末期分派每個基金單位約人民幣0.0189元,約等於0.0214港元。全年度之每個基金單位分派約人民幣0.0522元,約等於0.0580港元。按年計算的分派收益率為6.74%。- 為保持基金財務靈活性,於2025年7月1日至2025年12月31日期間的分派比率調整為90%,全年整體分派比率約為96%。廣州國金中心:- 廣州國金中心綜合體錄得經營收入為人民幣9.84億元,佔基金收入總額53.0%。- 廣州國金中心寫字樓引進兩家財富世界500強企業;出租率為80.9%。- 國金天地引進廣州首家且目前唯一的市內免稅店「中免免稅店」,全年續租率89%,期末出租率95.5%。- 廣州四季酒店平均房價同比提升5.8%,國金中心雅詩閣服務式公寓平均入住率達91.5%,同比增長1個百分點,營業收入創歷史同期新高。積極管理融資風險,有效平抑融資成本- 針對2025年到期的人民幣5.3億元短期貸款、21億港元5年期銀團貸款以及38億港元3年期銀團貸款餘下21億港元,管理人於2025年完成人民幣5.3億元短期貸款續借,並通過取得17億元人民幣離岸貸款、發行10億人民幣點心債以及21億港元等值境外銀團組合貸款(為可持續發展掛鉤貸款),用於到期貸款的再融資,確保流動性風險得到有效管控。- 年内合計引入人民幣46.8億元貸款,並部分置換境外浮息港元貸款,利用人民幣融資相對低位,主動調節融資結構。2025年年末融資利率敞口約為10%,較年初26%收窄16個百分點;平均融資成本為3.61%,創近三年新低,較年初4.16%下降55個基點;2025年全年平均付息率3.77%,同比下降76個基點。剔除匯兌虧損的融資成本約為人民幣7.73億元,同比減少約人民幣1.52億元。- 2025年年末人民幣融資約154.7 億元,佔總體融資76%(2024年:人民幣融資約123.3 億元,佔總體融資60%)。越秀房產基金主席及非執行董事江国雄先生表示:「2025年是越秀房產基金上市二十周年。管理人鞏固優勢,策略性搶佔市場份額,以出租率為優先考慮,強化風險管控穩定續租,匹配市場需求增強產品競爭力,投入資本性改造確保資產保值增值,在充滿挑戰的市場中穩定經營基本面,為全年經營收入提供堅實支撐。與此同時,我們優化資產組合,適當降低寫字樓業態佔比,並敏銳捕捉有利融資窗口,先後成功發行全球首筆上市REITs『熊貓債』及基金首筆綠債。全年融資成本創近三年新低,有效支撐整體分派水平。一系列開創性資本運作的成功實施,充分彰顯管理人推動越秀房產基金高質量發展的戰略目標,展現管理人為基金單位持有人創造可持續長遠價值的堅定決心。」國金中心國金中心年內新簽15,702平方米。推出7,403平方米帶裝修單元,去化週期約36天,去化率接近72%。引進優質租戶包括兩家財富世界500強背景企業、一家財富中國500強企業、一家全球龍頭航運企業和一家知名互聯網背景文體娛樂企業,續租34,294平方米,續租率86%,留存優質租戶包括六家財富世界500強企業和一家外國領事館。國金中心入選觀點「表現力指數·2025商辦資產運營表現」TOP30榜單。國金天地完成主力租戶「廣州友誼商店」續租;引進廣州首家且目前唯一的市內免稅店「中免免稅店」;落地負一層輕餐茶飲區、四樓和五樓餐飲業態品牌煥新,引進七家「首店」。會員運營成效顯著,會員銷售佔比翻倍式提升至16%。積極打造電子化消費場景,充分利用主流平台多渠道引流。聯動酒店、大劇院、博物館、領事館成功舉辦「意大利文化季」主題活動,有效促進客流與銷售轉化。新簽和續租合計35,573平方米,續租率89%。出租率為95.5%。廣州四季酒店年內首批改造客房年內入市,平均房價為人民幣2,260元,同比提升5.8%,平均入住率為77.7%;每間可供出租客房收入(RevPAR)為人民幣1,756元,同比增長0.9%;RevPAR競爭指數為110.0,在奢華酒店競爭群組中始終保持較領先的市場地位。國金中心雅詩閣服務式公寓期內平均入住率為91.5%,同比上升1個百分點;平均房價為人民幣1,137元,同比提升1.6%;RevPAR為人民幣1,040元,同比增長2.7%;RevPAR競爭指數達146.9,在高端公寓競品市場中維持高位。公寓營業收入創歷史同期新高,經營收入自2016年起連續十年穩居雅詩閣集團中國區第一名。越秀金融大廈管理人於第四季度出售越秀金融大廈50%權益。出售完成後,越秀金融大廈成為基金合資格少數權益物業。期末出租率為77.9%。白馬大廈白馬大廈引入廣州、深圳和東莞核心產業集群優質客戶,帶動全年新簽5,808平方米,一樓實現近五年首次滿租,二樓出租率創近六年新高。年內組織22家原創品牌亮相日本東京時尚產業展、及中國國際服裝服飾博覽會等專業展會;開展「白馬時尚行 · 邊貿供應鏈對接會」,與新疆烏魯木齊十家批發市場建立「粵新服飾產業鏈供採合作聯盟」。全年累計接待517個採購團,累計接待採購商近1.3萬人次,其中包括來自法國、越南等19個外商團,促成採購金額達人民幣3.2億元。期末出租率為96.0%。財富廣場財富廣場全年新簽6,334平方米,成功引進多家優質租戶,包括一家財富世界500強綜合金融集團旗下多家企業、兩家財富世界500強背景企業和兩家全球行業龍頭企業的廣州分支機構。續租8,662平方米,續租率84.0%,包括三家財富世界500強背景企業和一家全國性商業銀行廣州分行。升級產品標準加快空置單元去化,帶裝修單元去化率達93%。期末出租率為93.4%,同比上升1個百分點,出租率較中期強勁回升5.4個百分點。城建大廈城建大廈年內新簽9,279平方米,引進一家美容科技企業和一家醫藥供應鏈服務企業,提升樓內大健康業態氛圍。續租5,011平方米,續租率77%,包括一家財富世界500強企業和一家全球知名合同研究組織(CRO)企業。期末出租率為90.6%。維多利廣場維多利廣場主力租戶「優衣庫」繼續發揮旗艦作用,全年銷售額同比增長7.0%,蟬聯全國門店榜首。成功引進運動品牌「超級安踏」,打造廣佛地區最大門店;成功引入貴州香辣蟹全國首店「蟹莽莽」,豐富餐飲品牌組合。聯動內外部資源舉辦十五場大型活動,實現商場全年銷售額同比增長2.0%。全年新簽和續租合計5,579平方米,續租率84%。期末出租率為94.0%。上海越秀大廈上海越秀大廈全年續租6,430平方米,續租率43%;新簽8,070平方米,有效填補退租單元。持續匹配市場需求增加小面積帶裝修單元供應,制定差異化定價策略,成功舉辦渠道招商會,吸引百家中介機構參與,並投入多項資本性改造推動節能效益和服務水平持續提升。期末出租率為83.1%。武漢物業武漢越秀財富中心年內新簽26,837平方米,引進優質租戶包括兩家財富世界500強背景央企和兩家財富世界500強背景外資企業。續租20,617平方米,續租率76.0%創近三年新高,留存優質租戶包括七家財富世界500強背景企業和一家財富中國500強背景企業。全年改造單元供應約2.1萬平方米,去化率接近98%。期末出租率為62.1%,同比上升1個百分點。武漢星匯維港購物中心年內煥新多家熱門餐飲和健身品牌,吸引更多家庭和年輕客群,依託「悅花園」場地特色深度挖掘「夜經濟」與「場景體驗」消費潛力,舉辦「江畔星夜」主題活動,實現客流量同比基本持平,商場年度銷售額同比提升0.5%。全年新簽和續租合計9,827平方米,續租率48.0%。期末出租率為87.4%,較中期回升5.0個百分點。杭州維多利杭州維多利全年新簽7,890平方米,引進一家全層租戶。續租8,836平方米,續租率54%,留存優質租戶包括兩家財富世界500強背景企業和一家山西省屬國企的浙江分公司。期末出租率為84.5%。ESG融合業務,推進可持續發展管理人秉承長期主義理念,系統佈局ESG工作,值此連續第十年對外披露越秀房產基金可持續發展實踐之際,管理人正式將「環境、社會及管治報告」更名為「可持續發展報告」,以此進一步促進越秀房產基金戰略與可持續發展深度融合、同頻共進。年內,首次榮獲全球房地產可持續發展基準(GRESB)最高綠色五星評級及「全球行業領導者」稱號,公開披露再次獲最高「A」級等,彰顯了在可持續發展領域的卓越實力。未來展望未來一年,管理人將保持審慎樂觀的態度,「以變應變」強化風險管理,致力為基金單位持有人創造穩定回報。資產管理方面,將因應經濟發展走勢和競爭環境演變,動態實施積極、穩健、靈活的租賃和營運策略,發掘新增長點、把握潛在機會提升資產組合市場競爭力。融資管理方面,將持續對融資結構進行合理調整,通過各類融資途徑引入低成本人民幣融資,平滑利率風險。工程改造方面,將有序分段改造廣州四季酒店,護航物業長效保值增值。關於越秀房地產投資信託基金越秀房地產投資信託基金(「越秀房產基金」)於2005年12月21日在香港聯交所上市,為全球首隻投資於中國內地物業的上市房地產投資信託基金。截至2025年12月31日,越秀房產基金之物業組合共有十項(包括一項合資格少數權益物業),分別位於廣州的白馬大廈、財富廣場、城建大廈、維多利廣場、廣州國際金融中心、越秀金融大廈(合資格少數權益物業,實益權益49.495%)、位於上海的越秀大廈、位於武漢的武漢越秀財富中心、星匯維港購物中心、位於杭州的維多利商務中心及位於香港的越秀大廈。不包括越秀金融大廈,物業總建築面積約為97.4萬平方米,分別位於中國廣州市、上海市、武漢市、杭州市及香港市的核心商業區域。物業類型包括甲級寫字樓、商業綜合體、零售商業、酒店、服務式公寓、服裝專業市場等。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More
MarketingPulse and eTailingPulse open next Thursday ACN Newswire

MarketingPulse and eTailingPulse open next Thursday

HONG KONG, Mar 11, 2026 - (ACN Newswire via SeaPRwire.com) – Organised by the Hong Kong Trade Development Council (HKTDC), MarketingPulse and eTailingPulse – Asia’s premier annual e-commerce and marketing events – will be held concurrently on 19 March at the Hong Kong Convention and Exhibition Centre (HKCEC). Under the theme "Generate New Growth", this year's conferences focus on how brands can rethink their growth strategies amid global market uncertainty, helping to turn challenges into forward momentum. From strategic insights to practical implementation, the events will comprehensively reveal new directions for growth, bringing together about 70 global e-commerce experts, marketing executives, brand representatives and advertising elites to share valuable insights and success stories relating to global marketing and e-commerce trends. Featuring 30 thematic sessions, seminars and demonstration sessions, the events will help to foster cross-sector exchange and boost collaboration within the industry.The rise of e-commerce has injected new momentum into global economic growth, while the government is actively encouraging small and medium-size enterprises (SMEs) to develop e-commerce capabilities that can enhance their market competitiveness. This year’s conferences will focus on the latest developments in e-commerce, helping participants seize growth opportunities in the current market environment through a dual-track approach that advances both e-commerce development and brand marketing. A lineup of experts will speak on topics such as agentic AI, lifestyle e-commerce, quick commerce and global brand expansion. They will examine innovation in e-commerce along with global marketing trends and emerging consumer opportunities, while exploring how the industry can generate new growth amid a rapidly evolving marketing landscape.Tech marketing expert shares insights on data-driven growthJinhee Lee, Chief Operating Officer of Olive Young, South Korea’s leading health and beauty brand, will present on the theme “Beyond Retail, Building an Ecosystem: Driving Collaborative Growth of Olive Young and K-Beauty”. Drawing on perspectives from both marketing and e-commerce, he will explain how seamless omnichannel operations and data-driven marketing strategies are being leveraged to build a high-growth ecosystem for Korean beauty brands, while continuously expanding their global footprint. Well-known for harnessing data to drive innovation, Mr Lee has spearheaded a series of digital transformation initiatives and integrated retail strategies, using technology to enable Olive Young to stay ahead of trends and become a leader in the global beauty market.Breaking new ground in marketing through the China experience and new retailAtour Group is a leading player in Chinese Mainland’s mid- to high-end hotel chain market. Its Founder, CEO & Chief Experience Officer, Haijun Wang, will focus on two key themes during his presentation: 1) Experience Differentiation Strategy — placing differentiated experiences at the core to build distinctive product and service offerings across both the hotel and retail businesses; and 2) Customer Segment Operations Strategy — using a core customer base that pursues a quality lifestyle as the connective thread to deeply integrate the hotel and retail businesses, thereby shaping a unique brand group model.Enhancing brand value through aesthetic intelligence in e-commercePauline Brown, former Chairman of LVMH North America, will share how to leverage "aesthetic intelligence" to elevate brand value, shape consumer perception and strengthen overall online-to-offline experiences and marketing strategies. She will also discuss how brands can continuously cultivate "taste" and aesthetic acumen and explain how aesthetics and elevated storytelling can be utilised to build truly compelling brands in a rapidly changing e-commerce and technological landscape.Exploring the latest trends in agentic AI and quick commerceQuick commerce and agentic AI are bringing unprecedented changes to the e-commerce market in the Chinese Mainland, continuously reshaping consumers' shopping patterns, habits and demands. Yatong Qiu, Vice President of Taobao&Tmall Group, Alibaba, will share on how brands and merchants can tackle demand through flexible merchandising strategies, real-time marketing and speed-oriented innovations to maintain competitiveness and seize time-sensitive opportunities. Meanwhile, Terry Li, Vertical General Manager of Smart Retail, Tencent, will take a deeper dive into agentic AI-driven e-commerce strategies. Looking from the perspectives of service providers and e-commerce ecosystems, he will share practical approaches and future innovation directions for agentic AI solutions, helping brands and businesses seize the initiative in the new era of e-commerce.Decoding cross-border growth and market entry strategies for ASEANAs ASEAN continues to rise as one of the world's most dynamic economic regions, enterprises from the Chinese Mainland and Hong Kong are actively setting their sights on Southeast Asia, particularly seeking growth opportunities through e-commerce channels. The conferences will feature a session titled “Decoding the Gateway to ASEAN: Cross Border Growth and Market Entry Strategies”, exploring strategies for entering the ASEAN market. Speakers including Luca Barni, SVP, Commercial, Lazada Group, will share their practical experiences in expanding within ASEAN. Attendees will get a comprehensive understanding of the growth opportunities and common pitfalls in this growing market, addressing e-commerce legal and regulatory challenges, as well as brand and product localisation strategies.Cracking the Threads audience engagement plus celebrity insightsThe recent rise of social platform Threads is further driving the evolution of brand marketing models. In the "Threads for Consumer and Audience Engagement" session, Kenie Kwok, Creative Strategy Lead at Meta, will share the latest trends in brand account management and user preferences from the platform's perspective. Actor and "Threads Admin" Ng Siu-hin will share his insights on how to stand out as a content creator, offering practical tips on building engagement with netizens from a creator's viewpoint. In addition, IN.DECIDE, renowned for managing social media platforms for multiple brands as an "admin", will analyse its promotional campaign for the film Peg O' My Heart, detailing how the virtual character "Choi San-keung" successfully broke the fourth wall with the audience.This year's "Meet the Celebrity” dialogue series has invited actor and singer-songwriter Louis Cheung to speak on the topic "Chasing the Golden Boy Within". He will share his career journey in personal brand management and talk about his multifaceted development across the acting, music and creative fields. Meanwhile, content creator and MUSE TV Founder Mayao will discuss how he strategically leverages innovative promotional approaches to market music works, generating broad and lasting public impact and driving sustainable market growth.Exploring the “healing economy" and IP marketingWhen engaging with younger generations, who place strong emphasis on emotional connection, brands must understand “oshikatsu culture”, where young people identify strongly as a fan of an idol, along with the healing trend and intellectual property (IP)-driven consumer behaviour. The session "Healing Economy and IP Marketing" will feature speakers including Yiying Wang, Founder and Designer of Noodoll Limited, who will explore how brands can keep abreast of the latest trends, such as designing sustainably interactive experiences and campaigns with an "oshikatsu mindset", incorporating healing elements into products or marketing to enhance resonance, and collaborating with popular IPs to boost reach and engagement, thereby deepening connections and relationships with younger demographics.The conferences will introduce a new feature, "e-Commerce Connect", showcasing the latest one-stop e-commerce solutions, with close to 30 local and international exhibitors. Additionally, a series of digital marketing and e-commerce workshops will enable participating brands to gain hands-on practical experience. Multiple networking activities will be organised, and participants can take advantage of one-to-one business matching services to facilitate cross-sector exchange and collaboration. The event will also feature live music performances, including a set from popular local singer James Ng.For more information on speakers and the detailed programme for the conferences, please visit: https://marketingpulse.hktdc.com/conference/mp/en. To request interviews with guest speakers, please email betsytse@raconteur.hk or molisalau@raconteur.hk.Photo download: https://bit.ly/3OU0UArPauline Brown, Former Chairman of LVMH North AmericaHaijun Wang, Founder and CEO of Atour Lifestyle HoldingsJinHee Lee, Chief Operating Officer of Olive YoungLouis Cheung, Actor and singer-songwriterNg Siu-hin, Artist and "Threads Admin"MarketingPulse and eTailingPulse will be held on 19 March at the Hong Kong Convention and Exhibition Centre. Pictured are the MarketingPulse and eTailingPulse events held in 2025Websites· MarketingPulse: https://marketingpulse.hktdc.com/conference/mp/en· Event schedule: https://marketingpulse.hktdc.com/conference/mp/en/programme· Speaker list: https://marketingpulse.hktdc.com/conference/mp/en/speaker· eTailingPulse: https://etailingpulse.hktdc.com/conference/etp/en· EntertainmentPulse: https://hkfilmart.hktdc.com/conference/hkfilmart/en Media enquiriesFor enquiries, please contact:Raconteur PR Agency:Betsy TseTel: (852) 9742 7338Email: betsytse@raconteur.hkMolisa LauTel: (852) 6187 7786Email: molisalau@raconteur.hkHKTDC Communication and Public Affairs Department:Clayton LauwTel: (852) 2584 4472Email: clayton.y.lauw@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

Rubio 將阿富汗列為「非法拘留國家支持者」:痛斥其「卑劣手段」

(SeaPRwire) - 美國國務卿馬可·魯比奧(Marco Rubio)將阿富汗列為「非法拘留國家贊助者」,指責塔利班「不公正地」拘留美國人及其他外國公民。在週一的聲明中,魯比奧表示塔利班持續使用「恐怖手段」,並強調這些手段「必須停止」。「我將阿富汗指定為非法拘留國家贊助者,」魯比奧在聲明中說道。「塔利班持續使用恐怖手段,綁架個人以索取贖金或尋求政策讓步。這些卑劣的手段必須停止。」國務卿亦呼籲該恐怖組織釋放兩名在阿富汗被「不公正拘留」的美國人。「美國人前往阿富汗並不安全,因為塔利班持續不公正地拘留我們的美國同胞及其他外國公民,」他說。「塔利班需要立即釋放 Dennis Coyle、Mahmoud Habibi 以及所有在阿富汗被不公正拘留的美國人,並承諾永遠停止人質外交的行徑。」據 Dennis Coyle 的家人表示,64 歲的 Coyle 在一年多前被塔利班情報總局(Taliban General Directorate of Intelligence)拘留,且至今未被起訴。他的家人稱,他當時正以學術研究員的身分合法工作,致力於支持阿富汗語言社區。據美國國務院稱,38 歲的美國公民 Mahmoud Habibi 出生於阿富汗,2022 年 8 月在首都喀布爾與其司機一同被塔利班情報總局從車中帶走。聯邦調查局(FBI)表示,Habibi 曾任阿富汗民航局局長,並曾為喀布爾的電信公司 Asia Consultancy Group 工作。FBI 指出,塔利班當時還拘留了該公司的另外 29 名員工,但隨後釋放了其中大多數人。據美國國務院和 FBI 的說法,Habibi 自被捕後便音訊全無,塔利班也未透露其下落或健康狀況。塔利班此前曾否認拘留過 Habibi。據路透社援引兩名知情人士的消息,美國亦呼籲歸還作家 Paul Overby 的遺體,他最後一次被目擊是在 2014 年靠近阿富汗與巴基斯坦邊境的地方。消息人士向該媒體透露,如果塔利班不滿足美國政府的要求,國務院可能會限制美國護照前往阿富汗的使用。目前,這類護照限制僅針對北韓實施。塔利班稱魯比奧將阿富汗列為「非法拘留國家贊助者」的決定令人遺憾,並補充說希望透過對話解決此問題。塔利班於 2021 年美國軍隊從該國混亂撤軍、結束 20 年戰爭期間奪取了阿富汗的控制權。魯比奧在上個月底將「非法拘留國家贊助者」的稱號給予了伊朗,就在美以對該國發動襲擊的前一天。他當時警告稱,美國可能會因伊朗拘留美國公民而限制前往該國的旅行,但目前尚未實施任何限制。「伊朗政權必須停止劫持人質並釋放所有在伊朗被不公正拘留的美國人,這些步驟可以終止此項指定及相關行動,」魯比奧當時表示。路透社對本報導亦有貢獻。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD(TM) 2026 Annual Meeting JCN Newswire

Eisai to Present the Latest Data on Long-Term, Real-World Treatment with Lecanemab at the AD/PD(TM) 2026 Annual Meeting

TOKYO, Mar 11, 2026 - (JCN Newswire via SeaPRwire.com) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today the company will present the latest findings on lecanemab (generic name, U.S. brand name: LEQEMBI®), Eisai’s anti-amyloid beta (Aβ) protofibril antibody for the treatment of Alzheimer’s disease (AD), at the 20th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD™ 2026) from March 17-21, in Copenhagen, Denmark, and online. The lecanemab data and additional research findings from Eisai’s AD portfolio will be featured in six presentations, including three oral presentations. Eisai will host an industry-sponsored symposium.Oral and Poster PresentationsOral presentations will include the latest findings from a United States real-world long-term treatment persistence study, and efficacy and safety outcomes in apolipoprotein E ε4 (ApoEε4) homozygous carriers in a U.S. multicenter real-world study. In addition, four-year data from the Clarity AD Open-Label Extension trial in ApoEε4 non-carriers and heterozygotes, and a genome-wide association study on novel genetic variants associated with cognitive decline in AD will be presented as posters.Eisai Symposium – Continue Life Their Way: Early Intervention in Alzheimer’s DiseaseEisai is sponsoring a symposium featuring four leading global experts in the field of AD, on the topics of why early intervention matters, continuing early AD treatment and real-world outcomes. The symposium aims to enhance understanding of the value of early and continued anti-amyloid treatment in early AD by exploring how real-world evidence can support confident patient assessment in clinical practice, and how to recognize AD as a chronic condition that requires a multidisciplinary approach to care.Eisai serves as the lead of lecanemab development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making authority.AD/PD 2026 Presentations Relating to Eisai's Key Compounds and ResearchFor more information, please visit: https://www.eisai.com/news/2026/pdf/enews202612pdf.pdfMedia Inquiries:Public Relations Department,Eisai Co., Ltd.+81-(0)3-3817-5120Eisai Europe, Ltd.(Europe, Australia, New Zealand and Russia)EMEA Communications Department+44 (0) 7739-600-678EMEA-comms@eisai.netEisai, Inc. (U.S.)Julie Edelman+1-862-213-5915Julie Edelman@eisai.comAbout Lecanemab (generic name, brand name: Leqembi)Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma (IgG1) monoclonal antibody directed against aggregated soluble (protofibril) and insoluble forms of amyloid-beta (Aβ).Lecanemab has been approved in 53 countries and regions including Japan, the United States, China, Europe, South Korea, Taiwan, and Saudi Arabia, and is under regulatory review in 6 countries. Following the initial phase with treatment every two weeks for 18 months, intravenous (IV) maintenance dosing with treatment every four weeks was approved in 7 countries including the U.S., China, the UK, and others, and applications have been filed in 10 countries and regions. The U.S. FDA approved Eisai’s Biologics License Application (BLA) for subcutaneous maintenance dosing with LEQEMBI IQLIK in August 2025. A Supplemental Biologics License Application (sBLA) for initiation treatment was accepted in January 2026. The sBLA has been granted Priority Review, with a Prescription Drug User Fee Act (PDUFA) action date of May 24, 2026. In November 2025, an application for a subcutaneous injectable formulation in Japan was submitted. In January 2026, the Biologics License Application (BLA) for the subcutaneous formulation was accepted in China. In December 2025, Lecanemab (IV) has been included in the “Commercial Insurance Innovative Drug List”, recently introduced by the National Healthcare Security Administration (NHSA) of China.Since July 2020 the Phase 3 clinical study (AHEAD 3-45) for individuals with preclinical AD, meaning they are clinically normal and have intermediate or elevated levels of amyloid in their brains, is ongoing. AHEAD 3-45 is conducted as a public-private partnership between the Alzheimer's Clinical Trial Consortium that provides the infrastructure for academic clinical trials in AD and related dementias in the U.S, funded by the National Institute on Aging, part of the National Institutes of Health, Eisai and Biogen. Since January 2022, the Tau NexGen clinical study for Dominantly Inherited AD (DIAD), that is conducted by Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU), led by Washington University School of Medicine in St. Louis, is ongoing and includes lecanemab as the backbone anti-amyloid therapy.About ProtofibrilsProtofibrils are believed to contribute to the brain injury that occurs with AD and are considered to be the most toxic form of soluble Aβ, having a primary role in the cognitive decline associated with this progressive, debilitating condition.¹ Protofibrils cause injury to neurons in the brain, which in turn, can negatively impact cognitive function via multiple mechanisms, not only increasing the development of insoluble Aβ plaques but also increasing direct damage to brain cell membranes and the connections that transmit signals between nerve cells or nerve cells and other cells. It is believed the reduction of protofibrils may prevent the progression of AD by reducing damage to neurons in the brain and cognitive dysfunction.²About the Collaboration between Eisai and Biogen for ADEisai and Biogen have been collaborating on the joint development and commercialization of AD treatments since 2014. Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with both companies cocommercializing and co-promoting the product and Eisai having final decision-making authority.About the Collaboration between Eisai and BioArctic for ADSince 2005, Eisai and BioArctic have had a long-term collaboration regarding the development and commercialization of AD treatments. Eisai obtained the global rights to study, develop, manufacture and market lecanemab for the treatment of AD pursuant to an agreement with BioArctic in December 2007. The development and commercialization agreement on the antibody lecanemab back-up was signed in May 2015.References1. Amin L, Harris DA. Aβ receptors specifically recognize molecular features displayed by fibril ends and neurotoxic oligomers. Nat Commun. 2021;12: 3451. doi:10.1038/s41467-021-23507-z.2. Ono K, Tsuji M. Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer's Disease. Int J Mol Sci. 2020;21(3):952. doi: 10.3390/ijms21030952. PMID: 32023927; PMCID: PMC7037706. Copyright 2026 JCN Newswire via SeaPRwire.com. All rights reserved. www.jcnnewswire.com
More
國防股在衝突中停滯 Business

國防股在衝突中停滯

(SeaPRwire) - 國防產業在經歷了顯著的漲勢後,近期動能有所減弱。儘管中東地緣政治緊張局勢升級,這種放緩仍在發生。通常,由於政府增加軍事和國防資源的支出,此類全球衝突會提振國防股。 然而,近期市場趨勢顯示投資者正變得謹慎。這部分是出於對高估值和潛在市場修正的擔憂。儘管 Lockheed Martin (NYSE:LMT) 和 Northrop Grumman (NYSE:NOC) 等公司有所上漲,但該產業的整體表現並未達到今年稍早設定的預期。 分析師將這種乏善可陳的表現歸因於多個因素,包括地緣政治結果的不可預測性以及可能抑制國防開支的和談潛力。此外,全球經濟放緩也對全球國防預算造成壓力,導致投資者採取更為保守的態度。 另一個促成因素是利率上升,這使得尋求擴張或投資新國防技術的公司借貸成本更高。這種經濟環境導致了更具選擇性的投資策略,投資者傾向於選擇基本面強勁且較少受到市場波動影響的公司。 儘管面臨這些挑戰,國防產業在不確定時期仍被視為避險資產。投資者正密切關注政府合約和國防預算,以評估未來表現。授予國防巨頭用於先進武器和技術開發的合約,繼續為抵禦更廣泛的市場低迷提供緩衝。 此外,對網路安全和太空防禦日益增長的關注,正在為該產業創造新的增長機會。將其投資組合多元化以涵蓋這些新興領域的公司,更有能力利用未來的國防開支趨勢。 總之,儘管國防股目前的漲勢可能已經停滯,但對於尋求對沖地緣政治風險的投資者來說,該產業仍然是一個重要的關注領域。隨著全球格局不斷演變,擁有創新技術和戰略政府合作夥伴關係的國防公司,很可能引領潮流。 註腳: 本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 國防股歷來會因地緣政治緊張局勢而價值上漲。來源。
More
真主黨與伊朗對以色列發動協同集束炸彈攻擊,局勢顯著升級 News

真主黨與伊朗對以色列發動協同集束炸彈攻擊,局勢顯著升級

(SeaPRwire) - 一位國家安全專家聲稱,真主黨和伊朗週二發動了協同打擊策略,此前有報導稱致命的集束彈藥以同步襲擊的方式擊中以色列。這些事態發展發生在針對伊朗的美國與以色列聯合行動「史詩之怒」和「怒吼之獅」行動的第11天,標誌著不斷擴大的區域衝突可能升級。國家安全研究所和米斯加夫研究所的高級研究員科比·邁克爾在特拉維夫附近的防空洞中對 Digital 表示:「真主黨已全面參戰,看起來他們現在與伊朗協調得非常好。」他說:「真主黨的大部分火箭和無人機都是與伊朗導彈同時發射的。」據美聯社報導,以色列週二證實伊朗一直在發射集束彈藥——這對以色列捉襟見肘的防空系統來說,增加了一個複雜而致命的挑戰。彈頭在高空爆裂,將數十枚小型子彈藥散佈到廣闊區域。這些小型炸彈在夜間可能像橙色火球,難以攔截,並已被證明是致命的。記者內特·福伊也表示,儘管以色列的防空系統很強大,但一半的導彈難以防禦,因為一半的導彈是集束彈藥。邁克爾敦促:「伊朗使用集束導彈以及他們蓄意針對平民和民用設施的行為,必須被視為使用非傳統武器,美國與以色列的回應必須是適當的。」這些武器被120多個國家根據2008年集束彈藥公約禁用,因其廣泛、不加區分的影響,常導致災難性的平民傷害而受到廣泛譴責。邁克爾發表此番言論之際,路透社報導稱,真主黨正在吸取上次與以色列戰爭的教訓,為可能發生的以色列全面入侵和長期衝突做準備。報導稱,消息人士表示該組織正在回歸其在黎巴嫩南部的游擊戰根源。邁克爾還表示,「該國北部,海法地區,正遭受猛烈轟炸。」他說:「以色列公民必須大部分時間待在避難室裡,因為真主黨和伊朗蓄意針對平民和民用設施。」他補充說:「特拉維夫仍處於緊急狀態,警報持續不斷,許多人長時間待在防空洞裡。」他隨後強調:「以色列是一個小國,無法繼續容忍這種不對稱和這種消耗戰。」截至當地時間週二晚上,以色列國防軍表示已對貝魯特南部郊區的真主黨基礎設施發動了一波空襲。此前,軍方重申了撤離該地區的警告,該地區是真主黨的據點,被稱為達希耶。以色列國防軍在 X 上發布的帖子中說:「這就是我們正在打擊的目標。」路透社消息人士還聲稱,真主黨在地面上的大部分戰鬥迄今都集中在基亞姆鎮附近,該鎮位於黎巴嫩與以色列和敘利亞邊界的交界處。「我們希望川普總統不會停止,也不會使用他對青年運動使用的公式,即宣布勝利並讓受傷的獅子無法復仇和/或重組。」與此同時,據美聯社報導,一名不願透露姓名的以色列軍方官員週二表示,伊朗向以色列發射的彈藥中,大約一半現在是集束炸彈。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More

JOYY Reports 4Q and FY2025 Financial Results: Q4 Revenue Returns to YoY Growth, BIGO Ads Up 61.5% YoY

SINGAPORE, Mar 11, 2026 - (ACN Newswire via SeaPRwire.com) – JOYY Inc. (NASDAQ: JOYY) announced its unaudited financial results for the fourth quarter and full year of 2025.In the fourth quarter of 2025, JOYY’s total revenue was US$581.9 million, up 7.7% quarter over quarter and 5.9% year over year, marking a return to year-over-year revenue growth. Livestreaming revenue was US$394.4 million, up 1.5% quarter over quarter, marking the third consecutive quarter of sequential growth. BIGO Ads delivered accelerating revenue growth, up 61.5% year over year to US$128.1 million. For the full year of 2025, total revenue was US$2.12 billion. Livestreaming contributed US$1.53 billion, while BIGO Ads contributed US$398.5 million, up 38.5% year over year, driving total non-livestreaming revenue, including ad revenue and others, to 28.0% of the Company’s revenue, up 7.9 percentage points from 2024.In 2025, JOYY delivered steady profitability growth. Non-GAAP[1] operating income and non-GAAP[1] EBITDA were US$150.8 million and US$189.8 million, up 10.8% and 10.9% year over year, respectively. In the fourth quarter, non-GAAP1 operating income stood at US$40.8 million, and operating cash flow for the fourth quarter totaled US$116.0 million. As of December 31, 2025, the Company held US$3.26 billion in net cash.JOYY previously announced a shareholder return program of approximately US$900 million through dividends and share repurchases from 2025 through 2027. The Company has been actively executing its share repurchase program, with repurchases totaling US$67.4 million in the fourth quarter. In total, JOYY has distributed approximately US$332.0 million in dividends and share repurchases throughout 2025. In light of the double-digit improvements in operational profit in 2025, the Company will distribute an additional cash dividend of approximately US$20 million in the first quarter of 2026.Fourth Quarter 2025 Financial Highlights- Net revenues increased by 5.9% to US$581.9 million from US$549.4 million in the corresponding period of 2024 and by 7.7% from US$540.2 million in the third quarter of 2025.Livestreaming revenue was US$394.4 million, representing an increase of 1.5% from US$388.5 million in the third quarter of 2025.Advertising revenue increased by 62.4% to US$145.4 million from US$89.6 million in the corresponding period of 2024 and by 29.3% from US$112.5 million in the third quarter of 2025.Other revenues increased by 12.3% to US$42.1 million from US$37.5 million in the corresponding period of 2024 and by 7.2% from US$39.2 million in the third quarter of 2025.- Operating income was US$18.3 million.- Non-GAAP1 operating income was US$40.8 million.- Net Cash as of December 31, 2025 was US$3.26 billion.- Net cash from operating activities was US$116.0 million, compared with US$110.5 million in the corresponding period of 2024.Full Year 2025 Financial Highlights- Net revenues were US$2,124.2 million.- Operating income was US$55.8 million.- Non-GAAP1 operating income was US$150.8 million, up 10.8% from US$136.1 million in 2024.- Non-GAAP1 EBITDA was US$189.8 million, up 10.9% from US$171.2 million in 2024.[1]This press release includes certain non-GAAP financial measures as additional clarifying items to aid investors in further understanding the Company's performance and the impact that these items and events had on the financial results. The non-GAAP financial measures provided above should not be considered as a substitute for, or superior to, the measures of financial performance prepared in accordance with GAAP. For details of the non-GAAP measures, including the reconciliations of GAAP measures to non-GAAP measures, please refer to the press release titled “JOYY Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results” issued by the Company on March 11, 2026. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

歡聚集團發布2025年Q4財報及全年財報:BIGO Ads加速增長 股東回報強勁

新加坡, 2026年3月11日 - (亞太商訊 via SeaPRwire.com) - 歡聚集團(NASDAQ: JOYY)發布2025年第四季度及全年財報。2025年第四季度,歡聚營收5.819億美元,環比增長7.7%,同比增長5.9%,營收同比重回正增長軌道。公司直播業務收入環比增長1.5%達3.944億美元,連續三個季度實現環比增長;BIGO Ads收入增速持續提升,同比勁增61.5%至1.281億美元。2025年全年,公司累計營收達21.2億美元。其中,直播業務收入15.3億美元;BIGO Ads收入3.985億美元,同比增長38.5%,推動非直播整體收入占比提升至28%,較2024年提升7.9個百分點。2025年,歡聚集團盈利實現穩步增長。2025年全年,公司non-GAAP[1]經營利潤和non-GAAP[1] EBITDA(息稅折舊攤銷前利潤)分別為1.508億美元和1.898億美元,同比提升10.8%和10.9%。第四季度,歡聚non-GAAP1經營利潤達4080萬美元,經營性現金流達1.16億美元。截至2025年12月31日,集團淨現金達32.6億美元。在股東回饋方面,公司此前宣布,2025年至2027年回購及派息總計約9億美元。歡聚在2025年下半年加速回購,第四季度合計回購金額6740萬美元,全年共計回購金額1.346億美元。2025年全年,全年累計回購與派息金額約3.32億美元。考慮到2025年經營利潤兩位數的提升表現,在現有季度分紅計畫之外,歡聚將於2026年一季度額外派發2000萬美元現金分紅。2025年第四季度財務亮點- 淨收入為5.819億美元,2024年同期為5.494億美元,上季度為5.402億美元,同比增長5.9%,環比增長7.7%。直播收入為3.944億美元,上季度為3.885億美元,環比增長1.5%。廣告收入達1.454億美元,2024年同期為8960萬美元,同比增長62.4%;上季度為1.125億美元,環比增長29.3%。其他收入為4210萬美元,2024年同期為3750萬美元,同比增長12.3%;上季度為3920萬美元,環比增長7.2%。- 經營利潤為1830萬美元。- 非美國通用會計準則下1,經營利潤為4080萬美元。- 截至2025年12月31日,公司淨現金為32.6億美元。- 經營性現金流達1.16億美元,2024年同期為1.105億美元。2025年全年財務亮點- 淨收入為21.242億美元。- 經營利潤為5580萬美元。- 非美國通用會計準則下1,經營利潤為1.508億美元,2024年經營利潤為1.361億美元,同比增長10.8%。- 非美國通用會計準則下1,EBITDA為1.898億美元,2024年EBITDA為1.712億美元,同比增長10.9%。[1]本文涉及部分非美國通用會計準則指標(Non-GAAP)財務指標,以提供額外資訊,幫助投資者更方便評估公司核心業務表現,但不應被視為替代或優於按照美國通用會計準則(GAAP)編制的指標。投資者應同時參考GAAP和非GAAP指標,以獲得對公司財務表現的全面理解。關於美國通用會計準則指標與非美國通用會計準則指標之間的調整,詳細可查閱公司於2026年3月11日發佈的《JOYY 2025年第四季度及全年的財務業績》新聞稿。 Copyright 2026 亞太商訊 via SeaPRwire.com. All rights reserved. www.acnnewswire.com
More

致命的精銳「黑衣」殺手小組保護伊朗新任最高領袖莫傑塔巴·哈梅內伊

(SeaPRwire) - 據報導,在伊朗新任最高領袖大阿亞圖拉莫傑塔巴·哈梅內伊(Ayatollah Mojtaba Khamenei)的父親大阿亞圖拉阿里·哈梅內伊(Ayatollah Ali Khamenei)遇刺後,一支精銳反恐部隊已被部署保護他。這支部隊名為NOPO——伊朗的黑衣反恐特種部隊——在2月28日「史詩之怒行動」(Operation Epic Fury)啟動期間,美以聯軍襲擊德黑蘭一處地點導致老哈梅內伊死亡後,被指派保護這位領袖。「哈梅內伊去世後,NOPO現在將保護莫傑塔巴·哈梅內伊,」巴黎的伊朗全國抵抗委員會(National Council of Resistance of Iran,簡稱NCRI)外交事務委員會官員阿里·薩法維(Ali Safavi)表示。據薩法維介紹,這支部隊成立於1991年,最初是伊斯蘭革命衛隊(IRGC)第28魯霍拉師(以霍梅尼的名字命名)的「核心」,通常負責人質營救行動。該部隊的歷史還包括應對內部安全威脅的部署,並常被號召鎮壓抗議活動。伊朗專家會議於2026年3月8日選舉莫傑塔巴·哈梅內伊為伊斯蘭共和國第三位最高領袖。他的繼位正值伊朗與美國和以色列持續交戰之際,但截至目前,莫傑塔巴·哈梅內伊自衝突爆發以來一直未公開發聲。據《以色列時報》(The Times of Israel)報導,伊朗國家電視台稱莫傑塔巴·哈梅內伊在戰爭中受傷,相關報導尚未得到確認。薩法維進一步解釋:「NOPO是波斯語『Nirouyeh Vijeh Pasdaran Velayat』的縮寫,意為『保護最高領袖特種部隊』。」隨著時間推移,NOPO已演變為與更龐大的伊斯蘭革命衛隊(IRGC)截然不同的高度專業化部隊。IRGC是1979年成立的軍事分支,旨在防禦伊斯蘭共和國及其領導層免受內部和外部威脅。薩法維說:「NOPO僅由六個旅組成。四個駐紮在德黑蘭,一個在馬什哈德,一個在伊斯法罕。」他聲稱:「他們比IRGC更致命、更殘忍且訓練更有素」,隨後描述該旅的忠誠僅屬於最高領袖。薩法維繼續說:「這支部隊僅用於保護哈梅內伊。他們裝備非常精良。哈梅內伊不相信任何其他安全部隊能保護他。」薩法維還表示,該部隊的一些成員在阿里·哈梅內伊遇刺時喪生,但部隊仍全面運作。薩法維說:「一些NOPO成員在哈梅內伊遇刺時喪生,但事實是,他們現在參與了該政權近幾天為防止抗議爆發而採取的鎮壓和安全措施。」薩法維補充說,這支精銳部隊在危機時期的活動不僅限於人身保護。他說:「但在危機時期,比如1月起義期間,他們深度參與了向抗議者開槍的行動。」與此同時,有報導稱數百名NOPO成員已被廣泛部署在伊朗關押政治犯的監獄周圍。NCRI在一份聲明中表示:「數百名鎮壓部隊被廣泛部署在監獄周圍,包括蓋澤爾赫薩爾監獄(Ghezel Hesar Prison)。」2026年3月3日(週二),在馬哈巴德監獄(Mahabad Prison)附近的軍事中心發生爆炸後,牢房門被鎖的囚犯發起抗議,縱火焚燒毯子,要求根據戰時條件釋放他們。NCRI報導:「鎮壓部隊回應以向牢房發射催淚彈。」報導還顯示,在衝突加劇導致常規獄方人員逃離後,NOPO已接管德黑蘭的埃文監獄(Evin Prison)。2021年,美國財政部(U.S. Treasury Department)因NOPO對「伊朗境內人員、伊朗公民或居民,或上述人員的家屬」實施「嚴重人權侵犯」而對其實施制裁。本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。
More
Optiml 與 Scaler:攜手為機構投資組合提供端到端房地產決策智能 Business

Optiml 與 Scaler:攜手為機構投資組合提供端到端房地產決策智能

(SeaPRwire) -本文由第三方廠商內容提供者提供。SeaPRwire (https://www.seaprwire.com/)對此不作任何保證或陳述。 分類: 頭條新聞,日常新聞 SeaPRwire為公司和機構提供全球新聞稿發佈,覆蓋超過6,500個媒體庫、86,000名編輯和記者,以及350萬以上終端桌面和手機App。SeaPRwire支持英、日、德、韓、法、俄、印尼、馬來、越南、中文等多種語言新聞稿發佈。 瑞士蘇黎世、倫敦及阿姆斯特丹,2026年3月10日 — Optiml(ETH Zurich獲獎衍生企業,房地產決策智能(REDI)領域先驅)與Scaler(專為房地產行業打造的領先可持續性數據管理平台)今日宣佈建立戰略合作關係,旨在連接房地產數據基礎設施與機構級決策智能。該合作關係賦能 … Continue reading "Optiml and Scaler : Partnership to Deliver End‑to‑End Real Estate Decision Intelligence for Institutional Portfolios"
More